|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 231/38 | (2006.01) |
| C07D 405/10 | (2006.01) | ||
| C07D 233/88 | (2006.01) | ||
| A61K 31/415 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 1641764 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04777075.5 |
| Date of filing the European patent application | 2004-06-24 | |
| (97) | Date of publication of the European application | 2006-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2011-07-27 |
| (46) | Date of publication of the claims translation | 2011-11-25 |
| (86) | Number | PCT/US2004/020384 |
| Date | 2004-06-24 |
| (87) | Number | WO 2005/009973 |
| Date | 2005-02-03 |
| (30) | Number | Date | Country code |
| 483428 P | 2003-06-26 | US | |
| 499054 P | 2003-08-29 | US | |
| 560481 P | 2004-04-07 | US |
| (72) |
FRYSZMAN, Olga, M., US
LANG, Hengyuan, US
LAN, Jiong, US
CHANG, Edcon, US
FANG, Yunfeng, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | P38 kinazės inhibitoriai 5-narių heterociklų pagrindu |
| 5-MEMBERED HETEROCYCLE-BASED P38 KINASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2023-06-19 | 347.00 EUR |